Spectrum gets FDA plant approval; Hovione and Solvias pair up on co-crystals; Public Citizen wants compounders inspected;

> Spectrum Pharmaceuticals' new manufacturing site has received FDA approval for the production of Fusilev injection for use in advanced metastatic colorectal cancer patients. Item

> Hovione has buddied up with Solvias to combine formulation capabilities and crystal design for manufacturing pharmaceutical co-crystals. Release

> The USP will delay new elemental impurities standards to get them synced up with those in ICH Q3D. Item

> Watchdog group Public Citizen has requested that the FDA reinspect more than a dozen specialty pharmacies with prior records of violations in light of the lethal meningitis outbreak tied to drugs manufactured by New England Compounding Center. Story

And Finally... Johnson & Johnson ($JNJ) says it is making its HIV drug Prezista available to generics makers in Africa and developing countries. Story

Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.